When was Foundation Medicine founded?

Foundation Medicine was founded in 2010 and raised its 1st funding round within a year of its incorporation.

Where is Foundation Medicine located?

Foundation Medicine is headquartered in Cambridge, United States.

How many employees does Foundation Medicine have?

As of Mar 31, 2026, the latest employee count at Foundation Medicine is 1775.

Is Foundation Medicine a funded company?

Foundation Medicine is a funded company, having raised a total of $96.5M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Apr 15, 2010.

How much is Foundation Medicine worth?

The last known valuation of Foundation Medicine was $***** as of Jan 12, 2015.

When was the latest funding round of Foundation Medicine?

Foundation Medicine's latest funding was a $***** Series B round on Jan 08, 2013, with participation from 1 investor.

What is the annual revenue of Foundation Medicine?

Annual revenue of Foundation Medicine is $153M as on Dec 31, 2017.

Where does Foundation Medicine rank among its competitors?

Foundation Medicine ranks 4th amongst 564 active competitors, of which 146 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Delfi Diagnostics, which secured $34.3M in Dec, 2025.

Who are the top competitors of Foundation Medicine?

Foundation Medicine's top competitors include Guardant Health, Natera and Caris Life Sciences. Among them, Delfi Diagnostics secured the most recent funding round in December, 2025.

Foundation Medicine - 2026 Company Profile, Team, Funding, Competitors & Financials

Q: Is Foundation Medicine an acquired company?

Foundation Medicine got acquired by Roche on Jan 12, 2015.

Company Details

Provider of genomics-based diagnostics test for cancer. The company's clinical assays, FoundationOne for solid tumors, FoundationOne Heme for hematologic malignancies and sarcomas, and the liquid biopsy test FoundationACT provide a complete genomic profile of cancers, which oncologists can use to inform their treatment decisions. In addition, all tests provide an estimate of tumor mutational burden that enables oncologists to predict immunotherapy response as well.

Website: www.foundationmedicine.com/
Social
Email ID: *****@foundationmedicine.com
Phone Number: +1 **********

Key Metrics

Founded Year

2010

Location

Cambridge, United States

Stage

Acquired

Total Funding

$96.5M in 4 rounds

Latest Funding Round

Series B, Jan 08, 2013, $*****

Last Known Valuation

$***** as on Jan 12, 2015

Investors

Google Ventures & 12 more

Ranked

4^th among 564 active competitors

Annual Revenue

$153M as on Dec 31, 2017

Employee Count

1,775 as on Mar 31, 2026

Investment & Acquisitions

Saga Diagnostics & 1 more

Similar Companies

Guardant Health & 740 more

Exit Details

Acquired by Roche (Jan 12, 2015)

View Foundation Medicine's full profile

Foundation Medicine is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Foundation Medicine, Inc. CIN: 1488613 , United States, Active	Nov 11, 2009	$153M (As on Dec 31, 2017)	1707 (As on Dec 31, 2022)	-

Foundation Medicine got acquired by Roche on Jan 12, 2015 at an acquisition amount of $1B. It was facilitated by Goldman Sachs, Davis Polk, Goodwin and 1 more.

Click here to take a look at Foundation Medicine's acquisition in detail

Foundation Medicine has raised a total funding of $96.5M over 4 rounds. Its first funding round was on Apr 15, 2010. Its latest funding round was a Series B round on Jan 08, 2013 for $*****. 1 investor participated in its latest round. Foundation Medicine has 13 institutional investors.

Here is the list of recent funding rounds of Foundation Medicine:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 08, 2013	3425805	Series B	8169241	9802317	3095992	2500563
Sep 20, 2012	3048901	Series B	7036631	3437034	8681885	Third Rock Ventures & 2 more
Aug 23, 2011	1680135	Series A	8286721	6268552	Google Ventures & 1 more	Third Rock Ventures

Access funding benchmarks and valuations. Sign up today!

View details of Foundation Medicine's funding rounds and investors

The founders of Foundation Medicine are Todd Golub, Levi Garraway and Eric Lander.

Here are the details of Foundation Medicine's key team members:

Todd Golub: Co-founder of Foundation Medicine.
Levi Garraway: Co-Founder of Foundation Medicine and founder of 1 other company.
Contact Info: 1 email address
Eric Lander: Co-Founder of Foundation Medicine.
Contact Info: 1 email address

View details of Foundation Medicine's Founder profiles and Board Members

Foundation Medicine's employee count trend

Foundation Medicine has 1,775 employees as of Mar 26. Here is Foundation Medicine's employee count trend over the years:

Employee count trend for Foundation Medicine

Uncover Foundation Medicine's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Foundation Medicine include Guardant Health, Natera and Caris Life Sciences. Here is the list of Top 10 competitors of Foundation Medicine, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Guardant Health 2012, Redwood City (United States), Public	Developer of digital sequencing technology for cancer detection	$557M	SoftBank Vision Fund, Lightspeed Venture Partners ... & 24 others	79/100
2nd	Natera 2004, Redwood City (United States), Public	Developer of cell-free DNA testing for oncology, women’s health, and organ health	$152M	Harmony Partners, RA Capital Management & 17 others	77/100
3rd	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Coatue & 19 others	71/100
4th	Foundation Medicine 2010, Cambridge (United States), Acquired	Provider of genomics-based diagnostics test for cancer	$96.5M	Deerfield, Google Ventures & 11 others	71/100
5th	Exact Sciences 1995, Madison (United States), Acquired	Provider of non-invasive molecular diagnostic testing solutions for cancer	-	Petrillo Capital, Back Bay Group & 8 others	71/100
6th	Personalis 2011, Menlo Park (United States), Public	Provider of genomic sequencing and diagnosis software for the healthcare industry	$87.3M	Lightspeed Venture Partners, Abingworth & 4 others	70/100
7th	Prenetics 2009, Hong Kong (China), Public	Online platform for genetic and diagnostic health testing that helps identify health risks	$67.6M	Beyond Ventures, Ping An Ventures & 21 others	70/100
8th	BillionToOne 2015, San Francisco (United States), Public	Provider of cell-free cancer liquid biopsy test	$389M	Hummingbird Ventures, Adams Street Partners ... & 29 others	69/100
9th	Delfi Diagnostics 2019, Baltimore (United States), Series B	Provider of DNA sequencing for cancer detection	$332M	DFJ Growth, Merck Global Health Innovation Fund ... & 19 others	68/100
10th	Myriad Genetics 1991, United States, Public	Developer of molecular diagnostics and personalized medicine for cancer	-	Grayhawk Capital, TriplePoint Capital & 6 others	68/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Foundation Medicine's competitors? Click here to see the top ones

Foundation Medicine has acquired 2 companies including Saga Diagnostics and Lexent Bio. Foundation Medicine has not made any investments as of now.

Here is the latest report on Foundation Medicine's sector:

Free

Oncology - Sector Report

Edition: October, 2025 (81 Pages)

View all reports related to Foundation Medicine

Media has covered Foundation Medicine for a total of 10 events in the last 1 year, 4 of them have been about partnerships and 3 about company updates.